Sorrento Therapeutics (SRNE) Competitors $0.0006 +0.00 (+20.00%) As of 01:27 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSustainabilityTrends SRNE vs. ADXS, HEPA, ASLN, CWBR, REVB, PTEIQ, ENVB, EVFM, NMTR, and ADTXShould you be buying Sorrento Therapeutics stock or one of its competitors? The main competitors of Sorrento Therapeutics include Ayala Pharmaceuticals (ADXS), Hepion Pharmaceuticals (HEPA), ASLAN Pharmaceuticals (ASLN), CohBar (CWBR), Revelation Biosciences (REVB), PolarityTE (PTEIQ), Enveric Biosciences (ENVB), Evofem Biosciences (EVFM), 9 Meters Biopharma (NMTR), and Aditxt (ADTX). These companies are all part of the "pharmaceutical products" industry. Sorrento Therapeutics vs. Ayala Pharmaceuticals Hepion Pharmaceuticals ASLAN Pharmaceuticals CohBar Revelation Biosciences PolarityTE Enveric Biosciences Evofem Biosciences 9 Meters Biopharma Aditxt Ayala Pharmaceuticals (NASDAQ:ADXS) and Sorrento Therapeutics (NASDAQ:SRNE) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment, valuation and community ranking. Does the MarketBeat Community favor ADXS or SRNE? Sorrento Therapeutics received 610 more outperform votes than Ayala Pharmaceuticals when rated by MarketBeat users. Likewise, 68.16% of users gave Sorrento Therapeutics an outperform vote while only 0.00% of users gave Ayala Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAyala PharmaceuticalsOutperform VotesNo VotesUnderperform Votes73100.00% Sorrento TherapeuticsOutperform Votes61068.16% Underperform Votes28531.84% Which has more volatility & risk, ADXS or SRNE? Ayala Pharmaceuticals has a beta of 1.63, indicating that its stock price is 63% more volatile than the S&P 500. Comparatively, Sorrento Therapeutics has a beta of 1.68, indicating that its stock price is 68% more volatile than the S&P 500. Is ADXS or SRNE more profitable? Company Net Margins Return on Equity Return on Assets Ayala PharmaceuticalsN/A N/A N/A Sorrento Therapeutics N/A N/A N/A Does the media prefer ADXS or SRNE? In the previous week, Ayala Pharmaceuticals had 1 more articles in the media than Sorrento Therapeutics. MarketBeat recorded 1 mentions for Ayala Pharmaceuticals and 0 mentions for Sorrento Therapeutics. Ayala Pharmaceuticals' average media sentiment score of 0.00 equaled Sorrento Therapeutics'average media sentiment score. Company Overall Sentiment Ayala Pharmaceuticals Neutral Sorrento Therapeutics Neutral Do institutionals and insiders hold more shares of ADXS or SRNE? 7.2% of Ayala Pharmaceuticals shares are held by institutional investors. Comparatively, 0.0% of Sorrento Therapeutics shares are held by institutional investors. 0.6% of Ayala Pharmaceuticals shares are held by company insiders. Comparatively, 2.6% of Sorrento Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has preferable valuation & earnings, ADXS or SRNE? Ayala Pharmaceuticals has higher earnings, but lower revenue than Sorrento Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAyala Pharmaceuticals$10K448.04-$48.07M-$7.98-0.01Sorrento Therapeutics$62.84M0.01-$572.84MN/AN/A SummarySorrento Therapeutics beats Ayala Pharmaceuticals on 5 of the 9 factors compared between the two stocks. Get Sorrento Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRNE vs. The Competition Export to ExcelMetricSorrento TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$331,000.00$3.13B$5.81B$9.02BDividend YieldN/A1.57%4.78%3.85%P/E RatioN/A29.7126.2318.96Price / Sales0.01324.94453.4377.29Price / CashN/A183.5344.0437.47Price / BookN/A3.597.664.69Net Income-$572.84M-$71.72M$3.18B$245.69M7 Day PerformanceN/A-1.43%-1.36%-1.85%1 Month PerformanceN/A1.54%0.73%-1.54%1 Year PerformanceN/A-10.72%17.60%14.60% Sorrento Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRNESorrento TherapeuticsN/A$0.00+20.0%N/A-98.2%$331,000.00$62.84M0.00800Analyst ForecastGap DownADXSAyala PharmaceuticalsN/A$0.03+1.7%N/A-96.2%$1.28M$10,000.000.0020HEPAHepion Pharmaceuticals0.1519 of 5 stars$0.18-9.6%N/A-92.4%$1.27MN/A-0.0420ASLNASLAN PharmaceuticalsN/A$0.60flat$76.00+12,566.7%N/A$1.23M$12M-0.0330CWBRCohBarN/A$0.41flatN/AN/A$1.19MN/A0.0010REVBRevelation Biosciences0.1605 of 5 stars$4.28+2.9%N/A-90.3%$1.16MN/A-0.0210Negative NewsPTEIQPolarityTEN/A$0.15flatN/A+49.3%$1.09M$810,000.00-0.0560ENVBEnveric Biosciences0.948 of 5 stars$1.60+0.6%N/A-89.5%$1.09MN/A-0.0420EVFMEvofem BiosciencesN/A$0.01+3.3%N/A-71.9%$1.08M$18.22M-0.02120Gap UpNMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220ADTXAditxt0.9119 of 5 stars$0.07-6.5%N/A-99.9%$996,000.00$640,000.000.0060News CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies Ayala Pharmaceuticals Competitors Hepion Pharmaceuticals Competitors ASLAN Pharmaceuticals Competitors CohBar Competitors Revelation Biosciences Competitors PolarityTE Competitors Enveric Biosciences Competitors Evofem Biosciences Competitors 9 Meters Biopharma Competitors Aditxt Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SRNE) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sorrento Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
